Home Hospital for Bariatric Sleeve Gastrectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-23

Study Completion Date

2023-03-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Providing acute care at home for medicine patients is a well-studied care model. Providing acute care at home immediately following major surgery is less well understood. The investigators seek to demonstrate the noninferiority of care at home versus the hospital for patients undergoing bariatric sleeve gastrectomy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Role of Dietary Habits in Efficacy of Bariatric Surgery - Study B

NCT03467906

Bariatric Surgery Sleeve Gastrectomy Obesity

ACTIVE_NOT_RECRUITING

Role of Dietary Habits in Efficacy of Bariatric Surgery - Study A

NCT03470558

Bariatric Surgery Sleeve Gastrectomy Obesity

COMPLETED

Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C

NCT03482986

Bariatric Surgery Sleeve Gastrectomy Obesity

ACTIVE_NOT_RECRUITING NA

Telemedicine Follow-up for Bariatric Surgery Patients: What Do Patients Prefer

NCT04784286

Obesity

TERMINATED NA

The Feasibility and Acceptability of Utilizing Telehealth for Increasing Access to Bariatric Surgery

NCT05678179

Telehealth Face-2-Face (F2F)

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bariatric Surgery Candidate Bariatric Sleeve Gastrectomy Home Hospital

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control, Care in the Hospital

After bariatric sleeve gastrectomy, patients receive their care in the hospital, as usual.

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention, Care in the Home

After bariatric sleeve gastrectomy, patients receive their care in the home.

Group Type EXPERIMENTAL

Home hospital

Intervention Type OTHER

Acute care provided at home, including nurse/paramedic visits, physician visits, laboratory testing, imaging, continuous monitoring, 24/7 urgent visits, and specialty consultation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home hospital

Acute care provided at home, including nurse/paramedic visits, physician visits, laboratory testing, imaging, continuous monitoring, 24/7 urgent visits, and specialty consultation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All existing home hospital criteria apply, with the following taking precedent for this specific condition
* 21-55 years old
* Indication for bariatric laparoscopic sleeve gastrectomy per surgeon
* Caregiver capable of communicating with the home hospital team and able to stay in the same home as the patient the first night the patient is home

Exclusion Criteria

* All existing home hospital criteria apply, with the following taking precedent for this specific condition
* Comorbidities

* Body mass index\>55
* Chronic kidney disease
* Heart failure
* History of

* Chronic pain (with or without opioid use)
* Substance use disorder
* Venous thromboembolism
* Stroke
* Chronic headache
* Medications

* Anticoagulants and anti-platelets: aspirin, clopidogrel, warfarin, and direct oral anticoagulants
* Beta blockade
* Immunosuppressive
* Supplemental oxygen
* Allergy to ketorolac
* Prolonged QTc

Minimum Eligible Age

21 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No